MedComm – Future Medicine is a peer-reviewed english-language open-access journal published by Wiley in Australia, operating under an open-access model since 2022. The journal covers Medicine (General): Medical technology and Medicine (General): Computer applications to medicine. Medical informatics.
Authors are required to pay an article processing charge to publish in MedComm – Future Medicine; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, MedComm – Future Medicine has published 169 articles. Articles are minted with DOIs through the prefix 10.1002. All submissions undergo plagiarism screening before peer review.
Keywords
novel disease mechanisms, multiomics, precision medicine, medical artificial intelligence, regenerative medicine, bioinformatics
At a glance
- Publisher
- Wiley
- Country
- Australia
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Anonymous peer review
- OA since
- 2022
- Review time
- 15 weeks
- DOI prefix
10.1002- Plagiarism check
- Yes
ISSN
- electronic
- 2769-6456
Frequently asked questions
Is MedComm – Future Medicine peer-reviewed?
Does MedComm – Future Medicine charge an article processing charge (APC)?
What subjects does MedComm – Future Medicine publish?
What languages does MedComm – Future Medicine accept?
What is the ISSN of MedComm – Future Medicine?
2769-6456 (electronic).